Harvesting peripheral blood progenitor cells from healthy donors: retrospective comparison of filgrastim and lenograstim
Authors:
- 1 October 2005
- journal article
- research article
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 20 (3) , 129-136
Abstract
Mobilization of CD34+ into peripheral blood is attained by either glycosylated (lenograstim) or non‐glycosylated recombinant G‐CSF (filgrastim). 101 donors, 57 males, median age 42 years (range 16–63) entered this retrospective study. Group I (55 cases) received filgrastim and group II lenograstim subcutaneously for 5–6 days. The peak number of CD34+ cells/μl blood observed on day 4 and 5 was not significantly different in the two groups. No differences were shown in terms of both circulating CFU‐GM at the time of harvesting and CD34+ target of collection. The most frequent side effects were bone pain (18.2% grade I; 36.4% grade II, 7.3% grade III), headache (18.2%), nausea (9.1%), fever (5.5%) and a mild splenomegaly (>2cm) (5.5%) in filgrastim group, and bone pain (37.0% grade I, 26.1% grade II, 2.2% grade III), headache (17.4%), nausea (15.2%), fever (4.4%) and a mild splenomegaly (4.3%) in lenograstim group, respectively. CD34+ collection was associated with thrombocytopenia, which was not significantly different between the two groups. No donor in either group developed long‐term adverse effects. We conclude that both G‐CSFs are comparable in terms of CD34+ cell collection, safety and tolerability. J. Clin. ApheresisKeywords
This publication has 26 references indexed in Scilit:
- Stem cell mobilisation with 16 μg/kg vs 10 μg/kg of G-CSF for allogeneic transplantation in healthy donorsBone Marrow Transplantation, 2002
- Dose and Schedule Effect of G-GSF for Stem Cell Mobilization in Healthy Donors for Allogeneic TransplantationLeukemia & Lymphoma, 2002
- LenograstimDrugs, 2000
- Pharmacokinetics of glycosylated recombinant human granulocyte colony‐stimulating factor (lenograstim) in healthy male volunteersBritish Journal of Clinical Pharmacology, 1999
- Crossover study of the haematological effects and pharmacokinetics of glycosylated and non‐glycosylated G‐CSF in healthy volunteersBritish Journal of Haematology, 1997
- Haemopoietic growth factorsPostgraduate Medical Journal, 1997
- Prospective Randomized Study Comparing the Efficacy of Bioequivalent Doses of glycosylated and nonglycosylated rG‐CSF for Mobilizing Peripheral Blood Progenitor CellsBritish Journal of Haematology, 1997
- Human Granulocyte Colony-Stimulating Factor: Its Basic Aspects and Clinical ApplicationsJournal of Pediatric Hematology/Oncology, 1991
- Recombinant Human Granulocyte Colony-Stimulating Factor: Effects on Normal and Leukemic Myeloid CellsScience, 1986
- Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factorNature, 1986